Esomeprazole 2.5mg DR Pwdr Pkt Susp
Overview
What is this medicine?
How to Use This Medicine
To ensure you get the most out of your medication, follow these steps carefully:
1. Follow Your Doctor's Orders: Take this medication exactly as directed by your doctor. Read all the information provided to you and follow the instructions closely.
2. Timing and Preparation: Take your dose 1 hour before a meal. To prepare, mix the contents of the packet with water as follows:
For 2.5 mg or 5 mg packets, use 1 teaspoon (5 mL) of water.
For 10 mg, 20 mg, or 40 mg packets, use 1 tablespoon (15 mL) of water.
* If you need to take 2 packets, double the amount of water.
3. Mixing and Waiting: Stir the packet contents into the water, then let it sit for 2 to 3 minutes. After waiting, mix well and drink the entire dose within 30 minutes.
4. Disposal and Cleaning: Throw away any unused portion of the medication within 30 minutes of mixing. Rinse your cup with more water and drink to ensure you get the full dose.
5. Continuing Your Medication: Keep taking this medication as directed by your doctor or healthcare provider, even if you start to feel well.
Special Instructions for Feeding Tubes
If you have a feeding tube, your medication can still be given to you. Follow these steps:
1. Preparing the Medication: For 2.5 mg or 5 mg packets, add 5 mL of water to a syringe, then add the packet contents. For 10 mg, 20 mg, or 40 mg packets, add 15 mL of water to a syringe, then add the packet contents.
2. Mixing and Administering: Replace the plunger and shake the syringe. Let it sit for 2 to 3 minutes, then shake again and give the medication through the feeding tube.
3. Flushing the Tube: After giving the medication, refill the syringe with the same amount of water used, shake, and flush the feeding tube.
Storing and Disposing of Your Medication
To keep your medication safe and effective:
1. Storage: Store your medication at room temperature in a dry place, away from bathrooms.
2. Keeping it Safe: Keep all medications in a safe place, out of the reach of children and pets.
3. Disposal: Throw away unused or expired medications. Do not flush them down the toilet or pour them down the drain unless instructed to do so. Check with your pharmacist for the best way to dispose of your medication, and consider participating in drug take-back programs in your area.
What to Do if You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and go back to your normal schedule. Do not take two doses at the same time or extra doses.
Lifestyle & Tips
- Take this medicine at least 1 hour before your first meal of the day.
- Do not crush or chew the granules in the packet. Mix the powder with water as directed and swallow immediately.
- Avoid foods and drinks that trigger your acid reflux (e.g., spicy foods, fatty foods, caffeine, alcohol, citrus, chocolate).
- Eat smaller, more frequent meals.
- Avoid lying down for at least 3 hours after eating.
- Elevate the head of your bed if you experience nighttime reflux.
- Maintain a healthy weight.
- Quit smoking.
Available Forms & Alternatives
Available Strengths:
- Esomeprazole Magnesium 20mg DR Caps
- Esomeprazole Magnesium 40mg DR Caps
- Esomeprazole Magnesium 40mg DR Caps
- Esomeprazole Magnesium 20mg DR Caps
- Esomeprazole Pwdr 10mg DR For Susp
- Esomeprazole Pwdr 20mg DR For Susp
- Esomeprazole Pwdr 40mg DR For Susp
- Esomeprazole Sod 40mg Inj, 1 Vial
- Esomeprazole Mag 20mg DR Caps (otc)
- Esomeprazole Mag 20mg DR Caps (otc)
- Esomeprazole Mag 20mg DR Caps (otc)
- Esomeprazole 2.5mg DR Pwdr Pkt Susp
- Esomeprazole 5mg DR Pwdr Pkt Susp
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of electrolyte problems, including:
+ Mood changes
+ Confusion
+ Muscle pain, cramps, or spasms
+ Weakness
+ Shakiness
+ Changes in balance
+ Abnormal heartbeat
+ Seizures
+ Loss of appetite
+ Severe nausea or vomiting
Signs of kidney problems, such as:
+ Inability to urinate
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Severe dizziness or fainting
Bone pain
Significant weight loss
Symptoms of C. difficile-associated diarrhea (CDAD), including:
+ Stomach pain or cramps
+ Very loose or watery stools
+ Bloody stools
+ Do not attempt to treat diarrhea without consulting your doctor
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions, which can affect body organs and be life-threatening
+ Seek medical help immediately if you experience:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in your mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands
Other Possible Side Effects
Like all medications, this drug can cause side effects. Many people may not experience any side effects or only minor ones. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:
Headache
Stomach pain or diarrhea
Constipation
Gas
Dry mouth
Upset stomach
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe stomach pain or diarrhea that doesn't go away
- New or unusual bone pain or fractures
- Muscle spasms, tremors, or irregular heartbeat (signs of low magnesium)
- Unexplained weight loss
- Difficulty or pain when swallowing
- Black, tarry stools or vomit that looks like coffee grounds (signs of bleeding)
- New or worsening rash, especially on sun-exposed areas
- Signs of kidney problems (e.g., changes in urination, swelling in ankles/feet)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you are currently taking any of the following medications: Atazanavir, Clopidogrel, Methotrexate, Nelfinavir, Rifampin, Rilpivirine, St. John's Wort, or Warfarin.
* If you have a history of any of the following health issues:
+ Black or bloody stools
+ Heartburn accompanied by lightheadedness, sweating, dizziness, or wheezing
+ Chest pain
+ Shoulder pain with shortness of breath
+ Pain that radiates to the arms, neck, or shoulders
+ Lightheadedness
+ Excessive sweating
+ Vomiting blood
+ Difficulty or pain when swallowing food
Please note that this list is not exhaustive, and it is crucial to discuss all your medications (including prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. This will help ensure your safety while taking this medication. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Patients with weak bones (osteoporosis) should be aware that this medication may increase the risk of fractures in the hip, spine, and wrist. This risk may be higher if you take the drug in high doses, for more than a year, or if you are over 50 years old. If you have risk factors for osteoporosis, such as a history of alcohol consumption, smoking, steroid use, seizure medication, or a family history of osteoporosis, exercise caution and discuss your risks with your doctor.
Prolonged use of this medication (typically more than 3 months) may lead to rare but potentially serious side effects, including low magnesium levels. Most cases occur after at least 1 year of treatment, and low magnesium levels can cause other electrolyte problems. Your doctor may recommend regular blood tests to monitor your condition.
Long-term treatment with this medication (usually more than 3 years) has been associated with rare cases of low vitamin B-12 levels. Be aware of the symptoms of low vitamin B-12 levels, which may include shortness of breath, dizziness, abnormal heartbeat, muscle weakness, pale skin, tiredness, mood changes, or numbness or tingling in the arms or legs. If you experience any of these symptoms, contact your doctor immediately.
In rare cases, this medication has been linked to the development or worsening of lupus. If you have a history of lupus, inform your doctor, and seek medical attention immediately if you experience symptoms such as a rash on the cheeks or other body parts, changes in skin color, easy sunburn, muscle or joint pain, chest pain or shortness of breath, or swelling in the arms or legs.
Taking this medication for more than 1 year may increase the risk of developing stomach growths called fundic gland polyps. If you have concerns, discuss them with your doctor.
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor, as they will need to discuss the potential benefits and risks of this medication to you and your baby.
Overdose Information
Overdose Symptoms:
- Drowsiness
- Confusion
- Blurred vision
- Tachycardia (fast heart rate)
- Nausea
- Sweating
- Flushing
- Headache
- Dry mouth
What to Do:
Seek immediate medical attention or call a poison control center. In the US, call 1-800-222-1222. Treatment is generally supportive and symptomatic.
Drug Interactions
Major Interactions
- Clopidogrel (decreased antiplatelet effect)
- Nelfinavir, Atazanavir (decreased antiviral effect)
- Rilpivirine (decreased antiviral effect)
- Dasatinib, Erlotinib, Pazopanib, Sunitinib (decreased absorption of tyrosine kinase inhibitors)
- Methotrexate (increased methotrexate levels, potential toxicity)
Moderate Interactions
- Warfarin (increased INR/bleeding risk)
- Diazepam (decreased clearance of diazepam)
- Citalopram (increased citalopram exposure)
- Digoxin (increased digoxin absorption)
- Tacrolimus (increased tacrolimus levels)
- Iron salts (decreased iron absorption)
- Ketoconazole, Itraconazole, Posaconazole (decreased antifungal absorption)
- Mycophenolate mofetil (decreased mycophenolic acid exposure)
- St. John's Wort (decreased esomeprazole exposure)
- Rifampin (decreased esomeprazole exposure)
Minor Interactions
- Sucralfate (decreased esomeprazole absorption if given concurrently)
- Food (delays absorption, but not clinically significant for efficacy)
Monitoring
Baseline Monitoring
Rationale: To assess initial severity and guide treatment
Timing: Prior to initiation of therapy
Rationale: To establish baseline, especially in patients at risk for hypomagnesemia (e.g., concomitant diuretics, other drugs causing hypomagnesemia)
Timing: Prior to initiation of long-term therapy (>=3 months)
Routine Monitoring
Frequency: Periodically, as clinically indicated (e.g., at follow-up visits)
Target: Significant reduction or absence of symptoms
Action Threshold: Persistent or worsening symptoms may indicate need for dose adjustment, alternative therapy, or further diagnostic workup.
Frequency: Periodically (e.g., every 3-6 months) for patients on long-term therapy (>=3 months) or with risk factors
Target: Normal serum magnesium levels (1.7-2.2 mg/dL)
Action Threshold: Levels below normal range; consider supplementation or discontinuation of PPI if severe and persistent.
Frequency: Consider for patients at high risk for osteoporosis on long-term therapy (>1 year)
Target: Maintain healthy BMD
Action Threshold: Significant decline in BMD; consider calcium/vitamin D supplementation or alternative therapy.
Frequency: Consider for patients on very long-term therapy (>3 years) or with risk factors for B12 deficiency
Target: Normal serum B12 levels
Action Threshold: Levels below normal range; consider supplementation.
Symptom Monitoring
- Persistent or worsening heartburn
- Dysphagia (difficulty swallowing)
- Odynophagia (painful swallowing)
- Unexplained weight loss
- Recurrent vomiting
- Gastrointestinal bleeding (black, tarry stools; coffee-ground emesis)
- New or worsening diarrhea (especially watery or bloody)
- Muscle cramps, weakness, tremors, or arrhythmias (signs of hypomagnesemia)
- Fatigue, pallor, numbness/tingling (signs of B12 deficiency)
Special Patient Groups
Pregnancy
Esomeprazole is generally considered low risk during pregnancy (Pregnancy Category B). Studies in animals have not shown harm, and human data suggest no increased risk of major birth defects. Use only if clearly needed.
Trimester-Specific Risks:
Lactation
Esomeprazole is excreted into breast milk in small amounts (Lactation Risk L2 - Safer). The amount is generally considered too low to cause adverse effects in breastfed infants. Monitor infant for any signs of adverse effects (e.g., diarrhea, rash).
Pediatric Use
Approved for use in pediatric patients 1 month to 17 years for certain indications (GERD, erosive esophagitis). Dosing is weight-based for younger children. Safety and efficacy in infants younger than 1 month have not been established.
Geriatric Use
No overall differences in safety or effectiveness have been observed between elderly and younger patients. No dosage adjustment is generally needed based solely on age. However, elderly patients may be more susceptible to long-term adverse effects such as bone fractures and hypomagnesemia.
Clinical Information
Clinical Pearls
- Esomeprazole is the S-isomer of omeprazole, often marketed as a 'next-generation' PPI due to potentially more consistent pharmacokinetics.
- Administer 30-60 minutes before the first meal of the day to maximize efficacy, as the proton pumps are most active after a period of fasting.
- For patients unable to swallow capsules, the delayed-release powder for oral suspension is a suitable alternative.
- Long-term PPI use (especially >1 year) has been associated with increased risks of bone fractures (hip, wrist, spine), C. difficile infection, hypomagnesemia, and vitamin B12 deficiency. Periodically assess the need for continued therapy.
- PPIs can mask symptoms of gastric malignancy; consider endoscopy in patients with persistent symptoms despite therapy, or with alarm symptoms (e.g., weight loss, dysphagia, GI bleeding).
- Avoid concomitant use with clopidogrel due to potential reduction in clopidogrel's antiplatelet effect via CYP2C19 inhibition. Consider alternative antiplatelet therapy or alternative acid suppression if necessary.
Alternative Therapies
- Other Proton Pump Inhibitors (PPIs): Omeprazole, Lansoprazole, Pantoprazole, Rabeprazole, Dexlansoprazole
- H2-receptor antagonists (H2RAs): Famotidine, Ranitidine (withdrawn in some regions), Cimetidine, Nizatidine
- Antacids (e.g., calcium carbonate, aluminum hydroxide/magnesium hydroxide)
- Sucralfate (for ulcer treatment)
- Prokinetics (e.g., Metoclopramide, for motility disorders)